FDA approves first herbal medicine, Nibima, for clinical trial
The Food and Drugs Authority (FDA) has approved Ghana’s first herbal medicine for clinical trial on COVID-19 treatment.
This follows results from laboratory studies conducted by the Kwame Nkrumah University of Science and Technology (KNUST) research team.
This means the medicine, Cryptolepis Sanguinolenta, locally known as Nibima stands a better chance of being used to treat COVID-19 if it is approved after the trial.
A statement signed and released by FDA CEO Delese Darko said the authority remains committed to protect the health and safety of consumers.